Skip to content
OpenCapital
Get started

Rapid Micro Biosystems RPID Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$8.0MBeat by $402.0KDiluted EPS-$0.31Miss by $0.06
Revenue estimate$7.6M
EPS estimate-$0.25

Next report

Aug 11, 2026 (in a month)
Revenue estimate$7.9M
EPS estimate-$0.26

Financials

Q1 2026

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$86.69M-9.6%
Enterprise value$96.35M+12.0%
P/S2.5×-0.7×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Segments

By product

See full
Service$2.4M-21.9%

Versus estimates

Revenue

Q1 2026$8.0MBeat by $402.0K
Q4 2025$11.3MMiss by $68.0KQ3 2025$7.8MMiss by $3.1MQ2 2025$7.3MMiss by $1.1MQ1 2025$7.2MBeat by $338.3KQ4 2024$8.2MBeat by $18.0K

Diluted EPS

Q1 2026-$0.31Miss by $0.06
Q4 2025-$0.28Miss by $0.05Q3 2025-$0.26In lineQ2 2025-$0.27Miss by $0.01Q1 2025-$0.26Beat by $0.01Q4 2024-$0.22In line

Ask the moment Rapid Micro Biosystems reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rapid Micro Biosystems report Q1 2026 earnings?
Rapid Micro Biosystems (RPID) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Rapid Micro Biosystems's Q1 2026 revenue and EPS?
Rapid Micro Biosystems reported revenue of $8.0M and diluted EPS of $-0.31 for Q1 2026.
Did Rapid Micro Biosystems beat estimates in Q1 2026?
Revenue beat the consensus estimate of $7.6M by $402.0K. EPS missed the consensus estimate of $-0.25 by $0.06.
How did Rapid Micro Biosystems's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.1% from $7.2M a year earlier and diluted EPS declined 19.2% from $-0.26.
Where can I find Rapid Micro Biosystems's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001380106-26-000067) and the 10-Q periodic report (0001380106-26-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.